BSGM - Pangali PEG BioSig Technologies Inc.

Geopolitics and dependence on Asian chips create logistical risks for Biosig Technologies (BSGM). The PEG ratio on this chart illustrates the valuation dynamics, where the value is fixed at 0.00. Biosig Technologies generates revenue from cardiac signal analysis systems in high demand across clinics. However, funding shortages and low hospital demand have effectively erased its competitive advantages, despite its patent portfolio.

Biosig Technologies (BSGM), facing a liquidity shortage due to the slow implementation of diagnostic systems, requires strict monitoring of the relationship between market price and earnings dynamics. This metric compares the P/E ratio with the EPS growth rate, where values below one signal a fundamental undervaluation of the asset. By analyzing the PEG fair value filter, an investor determines the entry point into a "growth" business before a price correction occurs.